Company profile
Fiore Cannabis Ltd.
OTC: FIORF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Kelowna, BCReports USD
#771 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 28
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), listing tenure · ↓ market scale, disclosure history
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
-4.0%
Net income (FY)
-$7.1M
Employees
—
as of 2026-08-31
Market cap
$2.0k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.5M3.1M CAD2021
Net income-$7.1M-8.8M CAD2021
Operating income-$4.6M-5.7M CAD2021
Total assets$13.8M17.4M CAD2021
Liabilities$14.0M17.8M CAD2021
Equity-$269.0k-341.0k CAD2021
Revenue trend
FY2016 – FY2021 · USD
FY16
FY17
FY18
FY19
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Fiore Cannabis Ltd.’s revenue?
Fiore Cannabis Ltd. booked $2.5M in FY2021 revenue, growing 47% year over year — faster than most Healthcare companies we track, at a -280.9% net margin.
Peers · Healthcare
Innovative Eyewear, Inc.44DInfinity Pharmaceuticals, Inc.——ENvue Medical, Inc.46DGeoVax Labs, Inc.38DWayland Group Corp.——Lattice Biologics Ltd.——Key facts
CEOErik Anderson
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersKelowna, BC
ExchangeOTC: FIORF
Employees—
IPO date2015-09-01
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.